Liposaccharide natural compounds consisting of a trisaccharide repeating unit (two heptose units and octulosonic acid) with oligosaccharide side chains and 3-hydroxytetradecanoic acid units (they are a major constituent of the cell walls of Gram-negative bacteria).
Chemical ID:
MESH:D008070
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Lipopolysaccharides results in increased expression of IL1B; Lipopolysaccharides results in increased expression of IL1B mRNA; Lipopolysaccharides results in increased expression of IL1B protein
1,3-bis(4-hydroxyphenyl)-4-methyl-5-(4-(2-piperidinylethoxy)phenol)-1H-pyrazole inhibits the reaction [notoginsenoside R1 inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]]; 2,3-bis(4-hydroxyphenyl)-propionitrile inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; 2-(1-carboxy-2-(3-(3,5-dichlorobenzyl)-3H-imidazol-4-yl)ethylamino)-4-methylpentanoic acid inhibits the reaction [ACE2 protein inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [2-(1-carboxy-2-(3-(3,5-dichlorobenzyl)-3H-imidazol-4-yl)ethylamino)-4-methylpentanoic acid inhibits the reaction [ACE2 protein inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]]]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [7-Ala-angiotensin (1-7) inhibits the reaction [ACE2 protein inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]]]; 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; 3-methyladenine promotes the reaction [[Zearalenone co-treated with Lipopolysaccharides] results in increased expression of IL1B protein modified form]; 4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; 7-Ala-angiotensin (1-7) inhibits the reaction [ACE2 protein inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]]; [Arsenic Trioxide co-treated with Lipopolysaccharides] results in increased expression of IL1B protein; [Glycolipids analog co-treated with Lipopolysaccharides] results in increased expression of IL1B mRNA; [Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of IL1B protein; [Lipopolysaccharides co-treated with Titanium] results in increased expression of IL1B mRNA; [Lipopolysaccharides co-treated with TNF protein co-treated with IL1B protein] results in decreased expression of NFKBIA protein; [Lipopolysaccharides co-treated with TNF protein co-treated with IL1B protein] results in increased activity of NFKB1 protein; [Lipopolysaccharides co-treated with TNF protein co-treated with IL1B protein] results in increased activity of RELA protein; [Lipopolysaccharides co-treated with TNF protein co-treated with IL1B protein] results in increased expression of and results in increased activity of NOS2 protein; [Lipopolysaccharides co-treated with TNF protein co-treated with IL1B protein] results in increased expression of and results in increased activity of PTGS2 protein; [Particulate Matter co-treated with Lipopolysaccharides] results in increased expression of IL1B protein; [sodium arsenite co-treated with Lipopolysaccharides] results in increased expression of IL1B mRNA; [sodium arsenite co-treated with Lipopolysaccharides] results in increased expression of IL1B protein; [Zearalenone co-treated with Lipopolysaccharides] results in increased expression of IL1B mRNA; [Zearalenone co-treated with Lipopolysaccharides] results in increased expression of IL1B protein; [Zearalenone co-treated with Lipopolysaccharides] results in increased expression of IL1B protein modified form; ACE2 protein inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Acetylcysteine analog inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Acetylcysteine inhibits the reaction [[Buthionine Sulfoximine co-treated with Lipopolysaccharides] results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; AGTR2 protein inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Aminoimidazole Carboxamide analog promotes the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; arsenic disulfide inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; arsenic disulfide inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B mRNA]; Ascorbic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Aspirin inhibits the reaction [[Lipopolysaccharides co-treated with TNF protein co-treated with IL1B protein] results in increased activity of NFKB1 protein]; Aspirin inhibits the reaction [[Lipopolysaccharides co-treated with TNF protein co-treated with IL1B protein] results in increased activity of RELA protein]; butaprost inhibits the reaction [Lipopolysaccharides results in decreased degradation of IL1B protein]; Buthionine Sulfoximine promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Cannabidiol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; cannabigerol inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Carmustine promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Carrageenan promotes the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Ciprofloxacin inhibits the reaction [Irinotecan inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]]; Clenbuterol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Curcumin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; dorsomorphin inhibits the reaction [Aminoimidazole Carboxamide promotes the reaction [Lipopolysaccharides results in increased expression of IL1B protein]]; Drugs, Chinese Herbal inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Edaravone inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Estradiol inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; FBXO3 protein inhibits the reaction [MIR219A1 mRNA inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of IL1B protein]]; FBXO3 protein promotes the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of IL1B protein]; Fulvestrant inhibits the reaction [notoginsenoside R1 inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]]; GCG protein inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B]; Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; gossypin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; hydroquinone inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; IL1B protein affects the reaction [Lipopolysaccharides affects the expression of GHRL protein]; IMMLG5521 inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Irinotecan inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Lenalidomide inhibits the reaction [[Arsenic Trioxide co-treated with Lipopolysaccharides] results in increased expression of IL1B protein]; Lipopolysaccharides inhibits the reaction [Rutin results in decreased expression of IL1B mRNA]; Lipopolysaccharides promotes the reaction [Doxorubicin results in increased secretion of IL1B protein]; Lipopolysaccharides promotes the reaction [Zymosan results in increased expression of IL1B protein]; Lipopolysaccharides results in increased expression of and results in increased secretion of IL1B protein; loganin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Magnesium deficiency promotes the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; MIR16 inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; MIR219A1 mRNA inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of IL1B protein]; morroniside inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [[Arsenic Trioxide co-treated with Lipopolysaccharides] results in increased expression of IL1B protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [[Zearalenone co-treated with Lipopolysaccharides] results in increased expression of IL1B mRNA]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [[Zearalenone co-treated with Lipopolysaccharides] results in increased expression of IL1B protein modified form]; NANOG inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; NANOG inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; NFE2L2 protein affects the reaction [Probucol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]]; nitroaspirin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; nitroflurbiprofen inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; NLRP3 protein promotes the reaction [[Zearalenone co-treated with Lipopolysaccharides] results in increased expression of IL1B protein modified form]; notoginsenoside R1 inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Organoselenium Compounds inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Pentoxifylline inhibits the reaction [Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of IL1B protein]]; platycodin D inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Probucol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; pyrazolanthrone inhibits the reaction [2-(1-carboxy-2-(3-(3,5-dichlorobenzyl)-3H-imidazol-4-yl)ethylamino)-4-methylpentanoic acid inhibits the reaction [ACE2 protein inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]]]; pyrazolanthrone inhibits the reaction [7-Ala-angiotensin (1-7) inhibits the reaction [ACE2 protein inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]]]; pyrrolidine dithiocarbamic acid inhibits the reaction [[Zearalenone co-treated with Lipopolysaccharides] results in increased expression of IL1B mRNA]; pyrrolidine dithiocarbamic acid inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Rosiglitazone inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Rosiglitazone inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Roxithromycin inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Salicylates inhibits the reaction [[Lipopolysaccharides co-treated with TNF protein co-treated with IL1B protein] results in increased activity of NFKB1 protein]; Salicylates inhibits the reaction [[Lipopolysaccharides co-treated with TNF protein co-treated with IL1B protein] results in increased activity of RELA protein]; SB 203580 inhibits the reaction [2-(1-carboxy-2-(3-(3,5-dichlorobenzyl)-3H-imidazol-4-yl)ethylamino)-4-methylpentanoic acid inhibits the reaction [ACE2 protein inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]]]; SB 203580 inhibits the reaction [7-Ala-angiotensin (1-7) inhibits the reaction [ACE2 protein inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]]]; Sialic Acids inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Simvastatin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Sirolimus inhibits the reaction [[Zearalenone co-treated with Lipopolysaccharides] results in increased expression of IL1B protein modified form]; T0901317 inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Taurine inhibits the reaction [[Arsenic Trioxide co-treated with Lipopolysaccharides] results in increased expression of IL1B protein]; Taurine inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Tigecycline inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Tigecycline inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Triglycerides promotes the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; VCE-003 inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]
Lipopolysaccharides results in increased expression of IL1B; Lipopolysaccharides results in increased expression of IL1B mRNA; Lipopolysaccharides results in increased expression of IL1B protein
(+)-JQ1 compound inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; (+)-JQ1 compound inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; (N-(1-(((cyanoimino)(5-quinolinylamino) methyl) amino)-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide) inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased secretion of IL1B protein]; (N-(1-(((cyanoimino)(5-quinolinylamino) methyl) amino)-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide) inhibits the reaction [Adenosine Triphosphate inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]]; 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [[Lipopolysaccharides co-treated with aluminum sulfate] results in increased secretion of IL1B protein]; 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [[Lipopolysaccharides co-treated with nickel chloride] results in increased secretion of IL1B protein]; 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [ginsenoside Rg1 inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B]]; 1-dodecylsulfonyl-5N,6O-oxomethylidenenojirimycin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; 1-dodecylsulfonyl-5N,6O-oxomethylidenenojirimycin inhibits the reaction [Lipopolysaccharides results in increased metabolism of IL1B protein]; 2-(2-(4-heptylphenyl)ethyl)-6-hydroxy-benzoic acid inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; 2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]]; 2-Acetylaminofluorene inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; 2-chloro-4'-methoxychalcone inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; 2-oxothiazolidine-4-carboxylic acid inhibits the reaction [hydroxyethyl methacrylate inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]]; 24-norcholan-2,3,24-tryl-2,3,23-sulfuric acid inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; 3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-one inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; 3-(4-chlorophenylselanyl)-1-methyl-1H-indole inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; 3-(5-(2,3-dichlorophenyl)-1H-tetrazol-1-yl)methylpyridine inhibits the reaction [Silicon Dioxide analog promotes the reaction [Lipopolysaccharides results in increased expression of IL1B protein]]; 3-methyladenine inhibits the reaction [anemoside B4 inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]]; 3-methylquercetin inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of IL1B protein]; 3-methylquercetin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; 4-(4-fluorophenyl)sulfonyl-5-methylthio-2-phenyloxazole analog inhibits the reaction [[Palmitic Acid co-treated with Lipopolysaccharides] results in increased secretion of IL1B protein]; 4-(4-fluorophenyl)sulfonyl-5-methylthio-2-phenyloxazole analog inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; 4-(4-fluorophenyl)sulfonyl-5-methylthio-2-phenyloxazole inhibits the reaction [[Palmitic Acid co-treated with Lipopolysaccharides] results in increased expression of and results in increased cleavage of IL1B protein]; 4-(4-fluorophenyl)sulfonyl-5-methylthio-2-phenyloxazole inhibits the reaction [[Palmitic Acid co-treated with Lipopolysaccharides] results in increased secretion of IL1B protein]; 4-(4-fluorophenyl)sulfonyl-5-methylthio-2-phenyloxazole inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; 4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; 4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; 4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of IL1B protein]; 4-methylesculetin inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one analog inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one analog inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; 7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; 8-oxoberberine inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of IL1B mRNA]; 8-oxoberberine inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of IL1B protein]; [3-methylquercetin co-treated with Lipopolysaccharides] affects the expression of IL1B mRNA; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased expression of IL1B mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased expression of IL1B protein]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]]; [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Polystyrenes promotes the reaction [Lipopolysaccharides results in increased expression of IL1B protein]]; [Alendronate co-treated with Lipopolysaccharides] results in increased expression of IL1B protein; [bisphenol A affects the susceptibility to [Lipopolysaccharides co-treated with IFNG protein]] which results in decreased expression of IL1B mRNA; [Cholesterol co-treated with Lipopolysaccharides] results in increased secretion of IL1B protein; [Cisplatin co-treated with Lipopolysaccharides] results in increased expression of IL1B protein; [Cisplatin promotes the reaction [Lipopolysaccharides binds to TLR4 protein]] which results in increased expression of IL1B protein; [Dextran Sulfate co-treated with Lipopolysaccharides] results in increased expression of and results in increased secretion of IL1B protein; [Dextran Sulfate co-treated with Lipopolysaccharides] results in increased expression of IL1B mRNA; [Ethanol co-treated with Lipopolysaccharides] results in increased expression of IL1B mRNA; [Ethanol co-treated with Lipopolysaccharides] results in increased expression of IL1B protein; [ethion co-treated with Lipopolysaccharides] results in increased expression of IL1B protein; [ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate co-treated with cordycepin] inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; [ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate co-treated with cordycepin] inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; [ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate co-treated with cordycepin] inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; [ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate co-treated with diallyl trisulfide] inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; [Fenofibrate co-treated with Alitretinoin] inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; [Industrial Waste co-treated with Lipopolysaccharides] results in increased expression of IL1B mRNA; [Inorganic Chemicals co-treated with Lipopolysaccharides] results in increased expression of IL1B mRNA; [Irinotecan co-treated with Lipopolysaccharides] results in increased expression of and results in increased secretion of IL1B protein; [Irinotecan co-treated with Lipopolysaccharides] results in increased expression of IL1B mRNA; [Lipopolysaccharides co-treated with 1,4-bis(2-(3,5-dichloropyridyloxy))benzene] results in increased expression of IL1B mRNA; [Lipopolysaccharides co-treated with 2-oxothiazolidine-4-carboxylic acid] results in increased secretion of IL1B protein; [Lipopolysaccharides co-treated with 7alpha,8beta-dihydroxydeepoxysarcophine] results in decreased expression of IL1B protein; [Lipopolysaccharides co-treated with [Aluminum Hydroxide co-treated with Magnesium Hydroxide]] results in increased cleavage of and results in increased secretion of IL1B protein; [Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased cleavage of and results in increased secretion of IL1B protein; [Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased cleavage of IL1B protein; [Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of and results in increased activity of and results in increased secretion of IL1B protein; [Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of and results in increased secretion of IL1B protein; [Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of IL1B mRNA; [Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased secretion of and results in increased cleavage of IL1B protein; [Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased secretion of IL1B protein; [Lipopolysaccharides co-treated with Alum Compounds] results in increased cleavage of and results in increased secretion of IL1B protein; [Lipopolysaccharides co-treated with aluminum sulfate] results in increased expression of and results in increased activity of and results in increased secretion of IL1B protein; [Lipopolysaccharides co-treated with aluminum sulfate] results in increased secretion of IL1B protein; [Lipopolysaccharides co-treated with Benzo(a)pyrene] results in increased expression of IL1B mRNA; [Lipopolysaccharides co-treated with deoxynivalenol] results in increased expression of IL1B mRNA; [Lipopolysaccharides co-treated with deoxynivalenol] results in increased expression of IL1B protein; [Lipopolysaccharides co-treated with Galactosamine] results in increased expression of IL1B mRNA; [Lipopolysaccharides co-treated with Galactosamine] results in increased expression of IL1B protein; [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL1B mRNA; [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL1B protein; [Lipopolysaccharides co-treated with IFNG protein] results in increased secretion of IL1B protein; [Lipopolysaccharides co-treated with IFNG1 protein] results in increased expression of IL1B protein; [Lipopolysaccharides co-treated with Imiquimod] results in increased secretion of IL1B protein; [Lipopolysaccharides co-treated with indirubin-3'-monoxime] results in decreased secretion of IL1B protein; [Lipopolysaccharides co-treated with indole-3-carbinol] results in decreased secretion of IL1B protein; [Lipopolysaccharides co-treated with manganese chloride] results in increased expression of IL1B protein; [Lipopolysaccharides co-treated with nickel chloride] results in increased secretion of IL1B protein; [Lipopolysaccharides co-treated with Nigericin] results in increased cleavage of and results in increased secretion of IL1B protein; [Lipopolysaccharides co-treated with Nigericin] results in increased cleavage of IL1B protein; [Lipopolysaccharides co-treated with Nigericin] results in increased expression of IL1B protein; [Lipopolysaccharides co-treated with Nigericin] results in increased secretion of IL1B protein; [Lipopolysaccharides co-treated with ochratoxin A] results in increased expression of IL1B protein; [Lipopolysaccharides co-treated with Poly dA-dT] results in increased secretion of IL1B protein; [Lipopolysaccharides co-treated with Pregnenolone Carbonitrile] results in increased expression of IL1B mRNA; [Lipopolysaccharides co-treated with Silicon Dioxide] results in increased secretion of and results in increased cleavage of IL1B protein; [Lipopolysaccharides co-treated with SNCA protein] results in increased expression of IL1B mRNA; [Lipopolysaccharides co-treated with Thioglycolates] results in increased expression of IL1B mRNA; [Lipopolysaccharides co-treated with Uric Acid] promotes the reaction [PYCARD protein binds to CASP1 protein binds to IL1B protein binds to NLRP3 protein]; [Lipopolysaccharides co-treated with Uric Acid] results in increased expression of and results in increased activity of and results in increased secretion of IL1B protein; [Lipopolysaccharides co-treated with Uric Acid] results in increased expression of and results in increased secretion of IL1B protein; [Lipopolysaccharides co-treated with Uric Acid] results in increased expression of IL1B mRNA; [Lipopolysaccharides co-treated with Uric Acid] results in increased secretion of and results in increased cleavage of IL1B protein; [Lipopolysaccharides co-treated with Uric Acid] results in increased secretion of IL1B protein; [Lipopolysaccharides co-treated with Zymosan] results in increased expression of IL1B mRNA; [Lipopolysaccharides results in increased abundance of Prostaglandin D2] which results in increased expression of IL1B protein; [Monocrotaline co-treated with Lipopolysaccharides] results in increased secretion of IL1B protein; [Organic Chemicals co-treated with Lipopolysaccharides] results in increased expression of IL1B mRNA; [Palmitates co-treated with Lipopolysaccharides] results in increased expression of IL1B protein; [Palmitic Acid co-treated with Lipopolysaccharides] results in increased expression of and results in increased cleavage of IL1B protein; [Palmitic Acid co-treated with Lipopolysaccharides] results in increased secretion of IL1B protein; [picropodophyllin co-treated with Lipopolysaccharides] inhibits the reaction [IGF1 protein results in decreased expression of IL1B mRNA]; [picropodophyllin co-treated with Lipopolysaccharides] results in increased expression of IL1B mRNA; [Pioglitazone co-treated with Lipopolysaccharides] results in increased expression of IL1B mRNA; [procyanidin B3 co-treated with Eicosapentaenoic Acid] inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; [Quercetin co-treated with Lipopolysaccharides] affects the expression of IL1B mRNA; [Rimonabant co-treated with SR 144528] inhibits the reaction [OMDM-1 cpd inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]]; [RORA protein affects the susceptibility to Lipopolysaccharides] which affects the expression of IL1B; [Selenium co-treated with Lipopolysaccharides co-treated with IL4 protein] results in decreased expression of IL1B mRNA; [Silicon Dioxide co-treated with Lipopolysaccharides] results in increased expression of IL1B mRNA; [Silicon Dioxide co-treated with Lipopolysaccharides] results in increased secretion of IL1B protein; [Sirolimus results in decreased activity of MTOR protein] inhibits the reaction [Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]]; [Sirolimus results in decreased activity of MTOR protein] inhibits the reaction [Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]]; [sodium arsenite results in increased abundance of Arsenic] inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; [sodium arsenite results in increased abundance of Arsenic] inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; [SR 48968 co-treated with SR 140333] inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; [triptolide co-treated with Lipopolysaccharides] results in increased expression of IL1B mRNA; [triptolide co-treated with Lipopolysaccharides] results in increased secretion of IL1B protein; acetovanillone inhibits the reaction [[Lipopolysaccharides co-treated with Uric Acid] results in increased secretion of IL1B protein]; acetovanillone inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [NOX4 protein promotes the reaction [[Lipopolysaccharides co-treated with IFNG1 protein] results in increased expression of IL1B protein]]; Adenosine Triphosphate inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Adenosine Triphosphate promotes the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Adenosine Triphosphate promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; AHR protein affects the reaction [[Silicon Dioxide co-treated with Lipopolysaccharides] results in increased expression of IL1B mRNA]; AHR protein affects the reaction [[Silicon Dioxide co-treated with Lipopolysaccharides] results in increased secretion of IL1B protein]; AICA ribonucleotide inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; AIM2 protein promotes the reaction [[Lipopolysaccharides co-treated with Poly dA-dT] results in increased secretion of IL1B protein]; Alendronate promotes the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; alisol B 23-acetate inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of IL1B protein]; Alitretinoin inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; alpha-chaconine inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; alpha-chaconine inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; alpha-conotoxin PnIA analog promotes the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; alternaramide inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; alternaramide inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; anandamide inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; anemoside B4 inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Anti-Inflammatory Agents inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Antimicrobial Cationic Peptides inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Aporphines inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Aporphines inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; APPL1 protein inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Arsenic Trioxide inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of IL1B protein]; Arsenic Trioxide promotes the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; asarone inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Ascorbic Acid inhibits the reaction [Silicon Dioxide analog promotes the reaction [Lipopolysaccharides results in increased expression of IL1B protein]]; ASTM F-75 implant alloy promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; astragalin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; ATG5 protein affects the reaction [HU 308 inhibits the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased secretion of IL1B protein]]; ATG5 protein affects the reaction [MJN110 affects the reaction [Lipopolysaccharides affects the secretion of IL1B protein]]; Azithromycin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Azithromycin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Bee Venoms inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Berberine inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of IL1B mRNA]; Berberine inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of IL1B protein]; beta-amyrin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL1B mRNA]; beta-amyrin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL1B protein]; bisphenol A inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL1B mRNA]; bisphenol A promotes the reaction [[Cholesterol co-treated with Lipopolysaccharides] results in increased secretion of IL1B protein]; Buthionine Sulfoximine inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Buthionine Sulfoximine promotes the reaction [hydroxyethyl methacrylate inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]]; Butylated Hydroxyanisole inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; butyloxycarbonyl-phenylalanyl-leucyl-phenylalanyl-leucyl-phenylalanine inhibits the reaction [lipoxin A4 inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]]; butyloxycarbonyl-phenylalanyl-leucyl-phenylalanyl-leucyl-phenylalanine inhibits the reaction [lipoxin A4 inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]]; CA 074 methyl ester inhibits the reaction [[Lipopolysaccharides co-treated with Silicon Dioxide] results in increased secretion of IL1B protein]; Cadmium inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Cadmium inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; CALCA protein promotes the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; cardamonin inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Carthamus yellow inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Carticaine inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; carveol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; CASP1 protein affects the reaction [[Silicon Dioxide co-treated with Lipopolysaccharides] results in increased expression of IL1B mRNA]; CASP1 protein affects the reaction [AHR protein affects the reaction [[Silicon Dioxide co-treated with Lipopolysaccharides] results in increased expression of IL1B mRNA]]; CASP1 protein promotes the reaction [[Lipopolysaccharides co-treated with aluminum sulfate] results in increased secretion of IL1B protein]; CASP1 protein promotes the reaction [[Lipopolysaccharides co-treated with nickel chloride] results in increased secretion of IL1B protein]; CASP1 protein promotes the reaction [[Lipopolysaccharides co-treated with Poly dA-dT] results in increased secretion of IL1B protein]; CCR5 gene mutant form promotes the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; celastrol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; chaetoglobosins inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Chlorquinaldol inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased secretion of IL1B protein]; Chlorquinaldol inhibits the reaction [[Lipopolysaccharides co-treated with Imiquimod] results in increased secretion of IL1B protein]; Chlorquinaldol inhibits the reaction [[Lipopolysaccharides co-treated with Nigericin] results in increased cleavage of and results in increased secretion of IL1B protein]; Chlorquinaldol inhibits the reaction [[Lipopolysaccharides co-treated with Nigericin] results in increased secretion of IL1B protein]; Chlorquinaldol inhibits the reaction [[Lipopolysaccharides co-treated with Uric Acid] results in increased secretion of IL1B protein]; cholan-2,3,24-tryl-2,3,24-trisulfate inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Cholesterol promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Chromium Alloys promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; cinnamaldehyde inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; ciprofibrate inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Clopidogrel inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; CNR2 protein affects the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased expression of and results in increased secretion of IL1B protein]; CNR2 protein affects the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased expression of IL1B mRNA]; coagulin-L inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; coagulin-L inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; cobaltiprotoporphyrin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; cobaltiprotoporphyrin inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; cordycepin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; cordycepin inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; CRT 0066101 inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; CRT 0066101 inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Cryptoxanthins inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Curcumin analog inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Curcumin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; cyanoginosin LR inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; cynatratoside-C inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; cypermethrin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Cytochalasin D inhibits the reaction [[Lipopolysaccharides co-treated with Silicon Dioxide] results in increased cleavage of and results in increased secretion of IL1B protein]; Cytochalasin D inhibits the reaction [[Lipopolysaccharides co-treated with Uric Acid] results in increased cleavage of and results in increased secretion of IL1B protein]; Decitabine inhibits the reaction [[bisphenol A affects the susceptibility to [Lipopolysaccharides co-treated with IFNG protein]] which results in decreased expression of IL1B mRNA]; deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of IL1B protein]; Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Dexmedetomidine inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; diallyl disulfide inhibits the reaction [[Ethanol co-treated with Lipopolysaccharides] results in increased expression of IL1B protein]; diallyl disulfide inhibits the reaction [[Lipopolysaccharides co-treated with Uric Acid] results in increased secretion of IL1B protein]; diallyl trisulfide inhibits the reaction [[Lipopolysaccharides co-treated with Uric Acid] promotes the reaction [PYCARD protein binds to CASP1 protein binds to IL1B protein binds to NLRP3 protein]]; diallyl trisulfide inhibits the reaction [[Lipopolysaccharides co-treated with Uric Acid] results in increased expression of and results in increased secretion of IL1B protein]; diallyl trisulfide inhibits the reaction [[Lipopolysaccharides co-treated with Uric Acid] results in increased expression of IL1B mRNA]; diallyl trisulfide inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of IL1B protein]; diallyl trisulfide inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; diaoxinxuekang inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Diethylhexyl Phthalate inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL1B mRNA]; diphenyleneiodonium inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; diphenyleneiodonium inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; diphenyleneiodonium inhibits the reaction [Silicon Dioxide analog promotes the reaction [Lipopolysaccharides results in increased expression of IL1B protein]]; Disulfiram inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; dorsomorphin inhibits the reaction [AICA ribonucleotide inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]]; dorsomorphin inhibits the reaction [HU 308 inhibits the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased expression of IL1B protein]]; dorsomorphin inhibits the reaction [Quercetin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]]; dorsomorphin promotes the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Dronabinol inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of IL1B protein]; Drugs, Chinese Herbal inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Drugs, Chinese Herbal inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; DUSP1 gene mutant form inhibits the reaction [Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]]; DUSP1 gene mutant form inhibits the reaction [Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]]; Edaravone inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Edaravone inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; ENTPD1 protein inhibits the reaction [Silicon Dioxide analog promotes the reaction [Lipopolysaccharides results in increased expression of IL1B protein]]; epigallocatechin gallate inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; eriodictyol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; eriodictyol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Estradiol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL1B mRNA]; ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of IL1B protein]; ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate promotes the reaction [diallyl trisulfide inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]]; Ethylene Chlorohydrin promotes the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; FAAH protein affects the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Farnesol inhibits the reaction [[Alendronate co-treated with Lipopolysaccharides] results in increased expression of IL1B protein]; Fenofibrate inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Fenofibrate inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; ferulic acid inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; fidarestat inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; fidarestat inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; flavokawain A inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Fluoxetine inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Folic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Folic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B]; Folic Acid inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; fraxinellone inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; fucoxanthin analog inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; fucoxanthin inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of IL1B protein]; GATA2 affects the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; GATA2 affects the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Gemfibrozil inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; genipin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Genistein inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Genistein inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; geraniol inhibits the reaction [[Alendronate co-treated with Lipopolysaccharides] results in increased expression of IL1B protein]; geranylgeraniol inhibits the reaction [[Alendronate co-treated with Lipopolysaccharides] results in increased expression of IL1B protein]; gigantol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; gigantol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; ginsenoside Re inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; ginsenoside Re inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; ginsenoside Rg1 inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B]; ginsenoside Rg3 inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased secretion of IL1B protein]; GLRX protein promotes the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Glucosamine analog inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of IL1B protein]; Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; glutamyl-(2-(((3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-yl)oxy)carbonyl)-3-((2-(1H-indol-3-yl)ethyl)amino)-3-oxopropyl)-cysteinyl-glycine sodium salt inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; glutamyl-(2-(((3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-yl)oxy)carbonyl)-3-((2-(1H-indol-3-yl)ethyl)amino)-3-oxopropyl)-cysteinyl-glycine sodium salt inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; glyceryl-isoeugenol inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; glycyrol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Glycyrrhiza glabra extract inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Glycyrrhiza glabra extract inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; goniothalamin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; gypenoside LXXV inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased secretion of IL1B protein]; Hemin inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of IL1B protein]; hesperetin analog affects the reaction [PPARG protein affects the reaction [Lipopolysaccharides results in increased expression of IL1B protein]]; hesperetin analog inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; hesperetin analog inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; hesperetin inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Hesperidin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Hirudins inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased secretion of IL1B protein]; homoeriodictyol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; homoeriodictyol inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; HU 308 inhibits the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased expression of and results in increased secretion of IL1B protein]; HU 308 inhibits the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased secretion of IL1B protein]; hydroquinone inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; hydroquinone inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; hydroxyethyl methacrylate inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; hydroxyethyl methacrylate inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; hydroxyethyl methacrylate inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; hydroxyethyl methacrylate promotes the reaction [triethylene glycol dimethacrylate inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]]; IGF1 protein inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; IL10 protein affects the reaction [Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]]; IL10 protein inhibits the reaction [[Silicon Dioxide co-treated with Lipopolysaccharides] results in increased secretion of IL1B protein]; IL10 protein inhibits the reaction [AHR protein affects the reaction [[Silicon Dioxide co-treated with Lipopolysaccharides] results in increased secretion of IL1B protein]]; IL1B protein promotes the reaction [Lipopolysaccharides results in increased expression of PLSCR1 mRNA]; IL1R1 protein affects the reaction [[Lipopolysaccharides co-treated with [Aluminum Hydroxide co-treated with Magnesium Hydroxide]] results in increased cleavage of and results in increased secretion of IL1B protein]; IL1R1 protein affects the reaction [[Lipopolysaccharides co-treated with Alum Compounds] results in increased cleavage of and results in increased secretion of IL1B protein]; IL4 affects the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; IL4 affects the reaction [Rosiglitazone inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]]; IL6 protein affects the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Indirubin E804 inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; indirubin-3'-monoxime inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; indole-3-carbinol inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Industrial Waste inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL1B mRNA]; Industrial Waste inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Isothiocyanates inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; kaempferol 7-O-glucoside inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; kaempferol 7-O-glucoside inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; kaempferol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Ketamine inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Ketamine inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; kukoamine B inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of IL1B protein]; Latex promotes the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; LCN2 protein inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; leptomycin B inhibits the reaction [[Lipopolysaccharides co-treated with aluminum sulfate] results in increased expression of IL1B protein]; licochalcone B analog inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; licochalcone B analog inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Lipopolysaccharides promotes the reaction [deoxynivalenol results in increased expression of IL1B mRNA]; Lipopolysaccharides promotes the reaction [deoxynivalenol results in increased expression of IL1B protein]; Lipopolysaccharides promotes the reaction [Dinitrochlorobenzene results in increased expression of IL1B mRNA]; Lipopolysaccharides promotes the reaction [ethion results in increased expression of IL1B mRNA]; Lipopolysaccharides promotes the reaction [nickel chloride results in increased expression of IL1B mRNA]; Lipopolysaccharides promotes the reaction [Polystyrenes results in increased expression of IL1B mRNA]; Lipopolysaccharides promotes the reaction [Polystyrenes results in increased expression of IL1B protein]; Lipopolysaccharides promotes the reaction [satratoxin G results in increased expression of IL1B mRNA]; Lipopolysaccharides promotes the reaction [Shiga Toxin results in increased expression of IL1B mRNA]; Lipopolysaccharides promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of IL1B mRNA]; Lipopolysaccharides promotes the reaction [triphenyltin chloride results in increased expression of IL1B mRNA]; Lipopolysaccharides promotes the reaction [Zearalenone results in increased expression of IL1B mRNA]; Lipopolysaccharides results in increased expression of and results in increased activity of IL1B protein; Lipopolysaccharides results in increased expression of and results in increased secretion of IL1B protein; lipoxin A4 inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; lipoxin A4 inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; loganin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Lovastatin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; LRRK2 protein affects the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; luteolin 3'-glucuronide inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Luteolin inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; luteolin-7-O-glucuronide inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; lycium barbarum polysaccharide inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; lycium barbarum polysaccharide inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Mangifera indica extract inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL1B mRNA]; Masoprocol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; maytenonic acid inhibits the reaction [Lipopolysaccharides results in increased cleavage of IL1B protein]; maytenonic acid inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Melatonin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Melitten inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Memantine inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Menthol inhibits the reaction [[Alendronate co-treated with Lipopolysaccharides] results in increased expression of IL1B protein]; methyldithiocarbamate inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; methyldithiocarbamate inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; MGLL protein affects the reaction [Lipopolysaccharides affects the secretion of IL1B protein]; Minocycline inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; MIR381 mRNA affects the reaction [Dexmedetomidine inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]]; MIR381 mRNA inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; MIR483 mRNA promotes the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of IL1B protein]; MIR483 mRNA promotes the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; MIR99B mRNA affects the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; MIR99B mRNA affects the reaction [RELA protein affects the reaction [Lipopolysaccharides results in increased expression of IL1B protein]]; MJN110 affects the reaction [Lipopolysaccharides affects the secretion of IL1B protein]; mono-(2-ethylhexyl)phthalate inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL1B mRNA]; monotropein inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; monotropein inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; morin inhibits the reaction [[Lipopolysaccharides co-treated with Thioglycolates] results in increased expression of IL1B mRNA]; morin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; morroniside inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased cleavage of IL1B protein]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased secretion of IL1B protein]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [[Lipopolysaccharides co-treated with Nigericin] results in increased cleavage of IL1B protein]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [[Lipopolysaccharides co-treated with Nigericin] results in increased secretion of IL1B protein]; N-(4-O-glycerol-3-methoxybenzyl)nonivamide inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; N-acetyl-tyrosyl-valyl-alanyl-aspartyl chloromethyl ketone inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased cleavage of and results in increased secretion of IL1B protein]; naringenin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; naringenin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; NEAT1 affects the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; NFE2L2 protein affects the reaction [cobaltiprotoporphyrin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]]; NFE2L2 protein affects the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; NFE2L2 protein affects the reaction [salvianolic acid B inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]]; Nicotine inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; NLRP3 protein affects the reaction [[Lipopolysaccharides co-treated with [Aluminum Hydroxide co-treated with Magnesium Hydroxide]] results in increased cleavage of and results in increased secretion of IL1B protein]; NLRP3 protein affects the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased secretion of and results in increased cleavage of IL1B protein]; NLRP3 protein affects the reaction [[Lipopolysaccharides co-treated with Alum Compounds] results in increased cleavage of and results in increased secretion of IL1B protein]; NLRP3 protein affects the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL1B protein]; NLRP3 protein affects the reaction [[Lipopolysaccharides co-treated with Silicon Dioxide] results in increased secretion of and results in increased cleavage of IL1B protein]; NLRP3 protein affects the reaction [[Lipopolysaccharides co-treated with Uric Acid] results in increased secretion of and results in increased cleavage of IL1B protein]; NLRP3 protein promotes the reaction [[Lipopolysaccharides co-treated with aluminum sulfate] results in increased secretion of IL1B protein]; NLRP3 protein promotes the reaction [[Lipopolysaccharides co-treated with nickel chloride] results in increased secretion of IL1B protein]; NLRP3 protein promotes the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; NLRP3 protein promotes the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; NOTCH1 protein affects the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; NOTCH1 protein affects the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; notoginsenoside R1 inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; notoginsenoside R1 inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; NOX4 protein affects the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; NOX4 protein promotes the reaction [[Lipopolysaccharides co-treated with IFNG1 protein] results in increased expression of IL1B protein]; NSC 23766 inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Okadaic Acid inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of IL1B protein]; Okadaic Acid inhibits the reaction [[Lipopolysaccharides co-treated with Nigericin] results in increased expression of IL1B protein]; OMDM-1 cpd inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; OMDM-2 cpd inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; palmatine inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; palmatine inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; PARP1 protein affects the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Particulate Matter promotes the reaction [[Palmitates co-treated with Lipopolysaccharides] results in increased expression of IL1B protein]; Pentoxifylline promotes the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; PF 3845 inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; phenethyl isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; phlorofucofuroeckol A inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; PIAS1 protein inhibits the reaction [MIR483 mRNA promotes the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of IL1B protein]]; PIAS1 protein inhibits the reaction [MIR483 mRNA promotes the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]]; pirinixic acid inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; pirinixic acid inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Plant Extracts inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Plant Extracts inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Plant Extracts inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Plant Oils inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Plant Oils inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; PML protein promotes the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased secretion of IL1B protein]; PML protein promotes the reaction [[Lipopolysaccharides co-treated with Uric Acid] results in increased expression of IL1B protein]; PML protein promotes the reaction [[Lipopolysaccharides co-treated with Uric Acid] results in increased secretion of IL1B protein]; Polyethylene analog promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Polysaccharides inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Polysaccharides inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Polystyrenes promotes the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Polystyrenes promotes the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; PPARG protein affects the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; praeruptorin A inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; praeruptorin A inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; PRDM1 protein inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; PRDX6 protein inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased activity of IL1B protein]; PRDX6 protein inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; PRDX6 protein inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; PRDX6 protein inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; pterostilbene inhibits the reaction [[Lipopolysaccharides co-treated with Thioglycolates] results in increased expression of IL1B mRNA]; pterostilbene inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; PTGDR protein promotes the reaction [[Lipopolysaccharides results in increased abundance of Prostaglandin D2] which results in increased expression of IL1B protein]; PTPN1 protein promotes the reaction [[Ethanol co-treated with Lipopolysaccharides] results in increased expression of IL1B mRNA]; PTPN1 protein promotes the reaction [[Ethanol co-treated with Lipopolysaccharides] results in increased expression of IL1B protein]; PYCARD protein affects the reaction [[Lipopolysaccharides co-treated with [Aluminum Hydroxide co-treated with Magnesium Hydroxide]] results in increased cleavage of and results in increased secretion of IL1B protein]; PYCARD protein affects the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased secretion of and results in increased cleavage of IL1B protein]; PYCARD protein affects the reaction [[Lipopolysaccharides co-treated with Alum Compounds] results in increased cleavage of and results in increased secretion of IL1B protein]; PYCARD protein affects the reaction [[Lipopolysaccharides co-treated with Silicon Dioxide] results in increased secretion of and results in increased cleavage of IL1B protein]; PYCARD protein affects the reaction [[Lipopolysaccharides co-treated with Uric Acid] results in increased secretion of and results in increased cleavage of IL1B protein]; PYCARD protein promotes the reaction [[Lipopolysaccharides co-treated with aluminum sulfate] results in increased secretion of IL1B protein]; PYCARD protein promotes the reaction [[Lipopolysaccharides co-treated with nickel chloride] results in increased secretion of IL1B protein]; PYCARD protein promotes the reaction [[Lipopolysaccharides co-treated with Poly dA-dT] results in increased secretion of IL1B protein]; pyrazolanthrone inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; pyrazole analog inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Quercetin inhibits the reaction [[Lipopolysaccharides co-treated with Thioglycolates] results in increased expression of IL1B mRNA]; Quercetin inhibits the reaction [Cholesterol promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]]; Quercetin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Quercetin inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; RELA protein affects the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; resiniferatoxin promotes the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Resveratrol analog inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with Thioglycolates] results in increased expression of IL1B mRNA]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of IL1B protein]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Rimonabant inhibits the reaction [OMDM-1 cpd inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]]; Rimonabant promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Rosiglitazone inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; S-allylcysteine inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of IL1B protein]; salvianolic acid B inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; SB 203580 inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; sesamol inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Silicon Dioxide analog promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Silymarin inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of IL1B mRNA]; Silymarin inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of IL1B protein]; sinapinic acid inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Sirolimus inhibits the reaction [Ethylene Chlorohydrin promotes the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]]; sirtinol inhibits the reaction [Resveratrol inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]]; soyasaponin Ab inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; soyasaponin I inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; SR 144528 inhibits the reaction [OMDM-1 cpd inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]]; Sterols inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Sterols inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; sulforaphane inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL1B protein]; Tetrahydropapaveroline inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Tetrahydropapaveroline inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; TGFB1 protein inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; timosaponin B-II inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of IL1B protein]; TLR4 gene mutant form inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; TLR4 mutant form inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; TLR4 mutant form inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; TLR4 mutant form promotes the reaction [Ketamine inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]]; TLR4 mutant form promotes the reaction [Ketamine inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]]; Tobacco Smoke Pollution promotes the reaction [[Palmitates co-treated with Lipopolysaccharides] results in increased expression of IL1B protein]; tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; tofacitinib inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of IL1B protein]; tricarbonyldichlororuthenium (II) dimer inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; triethylene glycol dimethacrylate inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; triethylene glycol dimethacrylate inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; triethylene glycol dimethacrylate promotes the reaction [hydroxyethyl methacrylate inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]]; trilobatin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; trilobatin inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; triptolide promotes the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; tyrosyl-valyl-alanyl-aspartic acid fluoromethyl ketone analog inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; UOX protein inhibits the reaction [[Lipopolysaccharides co-treated with Uric Acid] results in increased secretion of IL1B protein]; vanadyl sulfate affects the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Vinyl Chloride metabolite promotes the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; WASF2 protein affects the reaction [LRRK2 protein affects the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]]; Wortmannin inhibits the reaction [Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of IL1B protein]]; Wortmannin inhibits the reaction [Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]]; yu ping feng san inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; yu ping feng san inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; zinc chloride inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased secretion of IL1B protein]]; Zinc Oxide promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; zinc protoporphyrin inhibits the reaction [2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]]; zinc protoporphyrin inhibits the reaction [8-oxoberberine inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of IL1B protein]]; zinc protoporphyrin inhibits the reaction [sesamol inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]]; Ziram inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]
1,3-dimethylthiourea inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; 10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-(1,4)diazepino(5',6'-4,5)thieno(3,2-f)quinolin-8-one inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; 15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; 15-keto-5,8,11,13-eicosatetraenoic acid inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; 2'-hydroxyflavanone inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; 2,5-dimethyl-4-benzoquinone inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; 2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester affects the reaction [Lipopolysaccharides affects the expression of IL1B protein]; 2-(5-benzo(1,3)dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine hydrochloride inhibits the reaction [Uric Acid promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]]; 2-chloro-5-nitrobenzanilide inhibits the reaction [Cannabidiol inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]]; 2-methyl-5-HT promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; 2-tert-butyl-4-quinone inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; 25-hydroxycholesterol promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; 27-hydroxycholesterol promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; 3,4,5,3',4'-pentachlorobiphenyl promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL1B mRNA]; 3-methyladenine promotes the reaction [[Acrolein co-treated with Lipopolysaccharides] results in increased expression of IL1B protein]; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; 6-formylindolo(3,2-b)carbazole affects the reaction [Lipopolysaccharides affects the expression of IL1B protein]; 6-formylindolo(3,2-b)carbazole promotes the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; 8-Hydroxy-2-(di-n-propylamino)tetralin promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; [Acetaminophen co-treated with Lipopolysaccharides] results in increased expression of IL1B mRNA; [Acrolein co-treated with Lipopolysaccharides] results in increased expression of IL1B protein; [Aluminum Oxide co-treated with Lipopolysaccharides] results in increased secretion of IL1B protein; [Aluminum Oxide co-treated with Nanotubes, Carbon co-treated with Lipopolysaccharides] results in increased secretion of IL1B protein; [Aluminum Oxide co-treated with Nanotubes, Carbon] promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; [Cadmium Chloride co-treated with Lipopolysaccharides] results in increased cleavage of IL1B protein; [Cadmium Chloride co-treated with Lipopolysaccharides] results in increased expression of IL1B mRNA; [Calcitriol co-treated with Lipopolysaccharides] results in increased expression of IL1B protein; [Calcitriol co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides co-treated with Nanotubes, Carbon] affects the expression of IL1B mRNA; [Calcitriol co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides co-treated with Nanotubes, Carbon] affects the expression of IL1B protein; [Calcitriol co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides co-treated with Nanotubes, Carbon] affects the secretion of IL1B protein; [Cholesterol co-treated with Lipopolysaccharides] results in increased expression of IL1B protein; [Disulfiram co-treated with Adenosine Triphosphate] inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased secretion of IL1B protein]; [Disulfiram co-treated with Zinc Sulfate] inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; [epigallocatechin gallate co-treated with gallocatechol co-treated with epicatechin gallate co-treated with Catechin analog] inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; [Ethanol co-treated with Lipopolysaccharides] results in increased cleavage of IL1B protein; [Ethanol co-treated with Lipopolysaccharides] results in increased expression of IL1B mRNA; [Glucose co-treated with Lipopolysaccharides] results in decreased expression of IL1B protein; [IFNG protein co-treated with Lipopolysaccharides] results in increased expression of IL1B mRNA; [IFNG protein, human co-treated with Lipopolysaccharides] results in increased expression of IL1B mRNA; [IFNG protein, human co-treated with Lipopolysaccharides] results in increased secretion of IL1B protein; [Irinotecan co-treated with Lipopolysaccharides] results in increased expression of and results in increased secretion of IL1B protein; [Irinotecan co-treated with Lipopolysaccharides] results in increased expression of IL1B mRNA; [Lipopolysaccharides co-treated with [Aluminum Hydroxide co-treated with Magnesium Hydroxide]] results in increased cleavage of and results in increased secretion of IL1B protein; [Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased cleavage of and results in increased secretion of IL1B protein; [Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased cleavage of IL1B protein; [Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of and results in increased cleavage of and results in increased secretion of IL1B protein; [Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of and results in increased secretion of IL1B protein; [Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of IL1B mRNA; [Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of IL1B protein; [Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased secretion of IL1B protein; [Lipopolysaccharides co-treated with Alum Compounds] results in increased cleavage of and results in increased secretion of IL1B protein; [Lipopolysaccharides co-treated with Bee Venoms] affects the expression of IL1B mRNA; [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL1B mRNA; [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL1B protein; [Lipopolysaccharides co-treated with IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of CCL2 mRNA; [Lipopolysaccharides co-treated with IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of CCL5 mRNA; [Lipopolysaccharides co-treated with IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of CXCL8 mRNA; [Lipopolysaccharides co-treated with IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of ICAM1 mRNA; [Lipopolysaccharides co-treated with IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of IFNGR1 mRNA; [Lipopolysaccharides co-treated with IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of IL1A mRNA; [Lipopolysaccharides co-treated with IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of IL1B mRNA; [Lipopolysaccharides co-treated with IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of IL6 mRNA; [Lipopolysaccharides co-treated with IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of NFKB1 mRNA; [Lipopolysaccharides co-treated with IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of NFKB2 mRNA; [Lipopolysaccharides co-treated with IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of NFKBIA mRNA; [Lipopolysaccharides co-treated with IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of NOD2 mRNA; [Lipopolysaccharides co-treated with IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of PLA2G2A mRNA; [Lipopolysaccharides co-treated with IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of SOD2 mRNA; [Lipopolysaccharides co-treated with IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of TNF mRNA; [Lipopolysaccharides co-treated with IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased secretion of CCL2 protein; [Lipopolysaccharides co-treated with IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased secretion of CXCL8 protein; [Lipopolysaccharides co-treated with IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased secretion of IL6 protein; [Lipopolysaccharides co-treated with IL1B protein co-treated with TNF protein] results in increased abundance of Dinoprostone; [Lipopolysaccharides co-treated with IL1B protein co-treated with TNF protein] results in increased abundance of Prostaglandin D2; [Lipopolysaccharides co-treated with IL1B protein co-treated with TNF protein] results in increased expression of PTGS2 mRNA; [Lipopolysaccharides co-treated with IL1B protein co-treated with TNF protein] results in increased expression of PTGS2 protein; [Lipopolysaccharides co-treated with nickel chloride] results in increased secretion of IL1B protein; [Lipopolysaccharides co-treated with Nicotine] results in increased expression of IL1B mRNA; [Lipopolysaccharides co-treated with Particulate Matter] results in decreased expression of IL1B protein; [Lipopolysaccharides co-treated with Silicon Dioxide] results in increased cleavage of and results in increased secretion of IL1B protein; [Lipopolysaccharides co-treated with Silicon Dioxide] results in increased secretion of IL1B protein; [Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL1B mRNA; [Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of IL1B protein; [Lipopolysaccharides co-treated with Tobacco Smoke Pollution analog] results in increased expression of IL1B mRNA; [Lipopolysaccharides co-treated with Uric Acid] results in increased cleavage of and results in increased secretion of IL1B protein; [Lipopolysaccharides co-treated with Uric Acid] results in increased expression of IL1B protein; [Lipopolysaccharides co-treated with Vehicle Emissions] results in decreased expression of IL1B protein; [Lipopolysaccharides results in decreased activity of TLR4 protein] inhibits the reaction [[Hyaluronic Acid metabolite binds to Acetates] which results in increased secretion of IL1B protein]; [MVK gene mutant form results in increased susceptibility to Lipopolysaccharides] which results in increased expression of IL1B protein; [Nanotubes, Carbon co-treated with Lipopolysaccharides] results in increased secretion of IL1B protein; [nickel chloride co-treated with Lipopolysaccharides] results in increased secretion of IL1B protein; [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of IL1B mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of IL1B mRNA; [Silicon Dioxide co-treated with Lipopolysaccharides] results in increased expression of IL1B mRNA; [Soot co-treated with Lipopolysaccharides] results in increased secretion of IL1B protein; [Spironolactone co-treated with Lipopolysaccharides] results in increased expression of IL1B protein; [tin protoporphyrin IX results in decreased activity of HMOX1 protein] results in decreased susceptibility to [surfactin peptide results in decreased susceptibility to [Lipopolysaccharides results in increased secretion of IL1B protein]]; [Uric Acid co-treated with TGFB1 protein] promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; [usnic acid co-treated with Lipopolysaccharides] results in decreased expression of IL1B mRNA; [Zinc co-treated with Lipopolysaccharides] results in increased expression of IL1B mRNA; acanthoic acid inhibits the reaction [[Ethanol co-treated with Lipopolysaccharides] results in increased cleavage of IL1B protein]; acanthoic acid inhibits the reaction [[Ethanol co-treated with Lipopolysaccharides] results in increased expression of IL1B mRNA]; Acetylcysteine inhibits the reaction [[Acrolein co-treated with Lipopolysaccharides] results in increased expression of IL1B protein]; Acetylcysteine inhibits the reaction [[Cadmium Chloride co-treated with Lipopolysaccharides] results in increased cleavage of IL1B protein]; Acetylcysteine inhibits the reaction [Acrolein promotes the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]]; Acetylcysteine inhibits the reaction [Acrolein promotes the reaction [Lipopolysaccharides results in increased expression of IL1B protein]]; Acetylcysteine inhibits the reaction [Lipopolysaccharides promotes the reaction [Acrolein results in increased expression of IL1B mRNA]]; Acetylcysteine inhibits the reaction [Lipopolysaccharides promotes the reaction [Acrolein results in increased expression of IL1B protein]]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Acrolein promotes the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Acrolein promotes the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Adenosine Triphosphate promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; AHR protein affects the reaction [Tetrachlorodibenzodioxin promotes the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]]; alisol B 23-acetate inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; alloin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; alpha-boswellic acid inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide promotes the reaction [daphnetin inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]]; Aluminum Oxide promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Amino Acids, Peptides, and Proteins inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Amrinone promotes the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; anandamide inhibits the reaction [[Lipopolysaccharides co-treated with IFNG] results in increased secretion of IL1B]; ANXA1 protein inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; ANXA1 protein inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Apigenin analog inhibits the reaction [Acrolein promotes the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]]; Apigenin analog inhibits the reaction [Lipopolysaccharides promotes the reaction [Acrolein results in increased expression of IL1B mRNA]]; Apigenin inhibits the reaction [Acrolein promotes the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]]; Apigenin inhibits the reaction [Lipopolysaccharides promotes the reaction [Acrolein results in increased expression of IL1B mRNA]]; Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; apigenin-6,8-di-C-glycopyranoside inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; arzanol inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Aspirin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; bafilomycin A inhibits the reaction [[Lipopolysaccharides co-treated with Silicon Dioxide] results in increased secretion of IL1B protein]; Beclomethasone inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Bee Venoms inhibits the reaction [[Lipopolysaccharides co-treated with Tobacco Smoke Pollution analog] results in increased expression of IL1B mRNA]; belnacasan inhibits the reaction [[Acrolein co-treated with Lipopolysaccharides] results in increased expression of IL1B protein]; benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; betulin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Budesonide inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Cadmium Chloride inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Cannabidiol inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Capsaicin promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Carvedilol inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; CASP1 protein affects the reaction [[Lipopolysaccharides co-treated with [Aluminum Hydroxide co-treated with Magnesium Hydroxide]] results in increased cleavage of and results in increased secretion of IL1B protein]; CASP1 protein affects the reaction [[Lipopolysaccharides co-treated with Alum Compounds] results in increased cleavage of and results in increased secretion of IL1B protein]; CASP1 protein affects the reaction [[Lipopolysaccharides co-treated with Silicon Dioxide] results in increased cleavage of and results in increased secretion of IL1B protein]; Catechin analog inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; CBR1 protein modified form inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Chromium promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; chrysin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Cilostazol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; cinnamaldehyde inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of IL1B protein]; CLEC4E protein promotes the reaction [[Cholesterol co-treated with Lipopolysaccharides] results in increased expression of IL1B protein]; coagulin-L inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; coagulin-L inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Cobalt promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; cobaltiprotoporphyrin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; CRT 0066101 inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; CRT 0066101 inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Cytochalasin D inhibits the reaction [[Lipopolysaccharides co-treated with Silicon Dioxide] results in increased cleavage of and results in increased secretion of IL1B protein]; Cytochalasin D inhibits the reaction [[Lipopolysaccharides co-treated with Uric Acid] results in increased cleavage of and results in increased secretion of IL1B protein]; daphnetin inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Deferoxamine promotes the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; delta-8-tetrahydrocannabinol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG] results in increased secretion of IL1B]; deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Dimethyl Sulfoxide inhibits the reaction [[Lipopolysaccharides co-treated with IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased secretion of CCL5 protein]; Dimethyl Sulfoxide inhibits the reaction [[Lipopolysaccharides co-treated with IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased secretion of IL6 protein]; Disulfiram inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased secretion of IL1B protein]; Docosahexaenoic Acids analog inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; doramapimod inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Dronabinol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG] results in increased secretion of IL1B]; Edaravone inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Edaravone inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; EIF2AK2 protein affects the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; EIF2AK2 protein affects the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Epinephrine inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Ethylmercury Compounds inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Eugenol inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of IL1B protein]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of IL1B protein]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; EVP 4593 inhibits the reaction [[Lipopolysaccharides co-treated with Irinotecan] results in increased expression of and results in increased secretion of IL1B protein]; FANCA mRNA alternative form affects the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Farnesol inhibits the reaction [[MVK gene mutant form results in increased susceptibility to Lipopolysaccharides] which results in increased expression of IL1B protein]; ferric chloride inhibits the reaction [Deferoxamine promotes the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]]; fraxinellone inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; geraniol inhibits the reaction [[MVK gene mutant form results in increased susceptibility to Lipopolysaccharides] which results in increased expression of IL1B protein]; geranylgeraniol inhibits the reaction [[MVK gene mutant form results in increased susceptibility to Lipopolysaccharides] which results in increased expression of IL1B protein]; GGTI 298 promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; glucosamine 6-O-sulfate inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; glucosamine 6-O-sulfate inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; glucosamine 6-O-sulfate inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; GW 506033X inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; GW 506033X inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; hesperetin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Hesperidin inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; HMOX1 mutant form inhibits the reaction [Cilostazol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]]; HNRNPD protein inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; honokiol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; HOXA-AS2 inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; HTR3A protein promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; HTR4 protein promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; HTR7 protein promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Ibuprofen inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; IL10 protein affects the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; IL13 protein inhibits the reaction [[Calcitriol co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides co-treated with Nanotubes, Carbon] affects the secretion of IL1B protein]; IL4 protein inhibits the reaction [[Calcitriol co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides co-treated with Nanotubes, Carbon] affects the secretion of IL1B protein]; indole-3-carbinol promotes the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Indomethacin inhibits the reaction [[Lipopolysaccharides co-treated with IL1B protein co-treated with TNF protein] results in increased abundance of Dinoprostone]; Indomethacin inhibits the reaction [[Lipopolysaccharides co-treated with IL1B protein co-treated with TNF protein] results in increased abundance of Prostaglandin D2]; Indomethacin promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; JHW 015 inhibits the reaction [[Lipopolysaccharides co-treated with IFNG] results in increased secretion of IL1B]; KN 62 inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased cleavage of IL1B protein]; Lipofundin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Lipofundin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Lipopolysaccharides inhibits the reaction [swietenine inhibits the reaction [Glucose results in increased expression of IL1B protein]]; Lipopolysaccharides promotes the reaction [Acrolein results in increased expression of IL1B mRNA]; Lipopolysaccharides promotes the reaction [Acrolein results in increased expression of IL1B protein]; Lipopolysaccharides promotes the reaction [Coal Tar results in increased expression of IL1B mRNA]; Lipopolysaccharides promotes the reaction [Glucose results in increased expression of IL1B protein]; Lipopolysaccharides promotes the reaction [Nanotubes, Carbon results in increased expression of IL1B protein]; Lipopolysaccharides promotes the reaction [Silver results in increased secretion of IL1B protein]; Lipopolysaccharides promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of IL1B mRNA]; Lipopolysaccharides results in increased expression of and results in increased cleavage of and results in increased secretion of IL1B protein; Lipopolysaccharides results in increased expression of and results in increased secretion of IL1B protein; Luteolin inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of IL1B protein]; mancozeb inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; manoalide inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Menthol inhibits the reaction [[MVK gene mutant form results in increased susceptibility to Lipopolysaccharides] which results in increased expression of IL1B protein]; Mercuric Chloride inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Mercuric Chloride promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Mercury promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Methamphetamine promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Methylmercury Compounds promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; MIR106B mRNA inhibits the reaction [HOXA-AS2 inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]]; MIR152 mRNA affects the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; MIR17 affects the reaction [FANCA mRNA alternative form affects the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]]; MIR17 inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; MitoTEMPO inhibits the reaction [[Cadmium Chloride co-treated with Lipopolysaccharides] results in increased cleavage of IL1B protein]; monophosphoryl lipid A inhibits the reaction [USP18 protein inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]]; N-(1-azabicyclo(2.2.2)oct-3-yl)furo(2,3-c)pyridine-5-carboxamide inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; N-(1-azabicyclo(2.2.2)oct-3-yl)furo(2,3-c)pyridine-5-carboxamide inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; NFKBIA protein inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Nicotine inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Nicotine inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; NLRP3 protein affects the reaction [[Acrolein co-treated with Lipopolysaccharides] results in increased expression of IL1B protein]; NLRP3 protein inhibits the reaction [PRKAA1 protein inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]]; NLRP3 protein promotes the reaction [[Cadmium Chloride co-treated with Lipopolysaccharides] results in increased cleavage of IL1B protein]; NLRP3 protein promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Particulate Matter promotes the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; phenylbenzoquinone inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; pimobendan promotes the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Plant Extracts inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Plant Extracts inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Polymyxin B inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Prednisolone inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; PRKAA1 protein inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; PRKAA1 protein promotes the reaction [puerarin inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]]; Propofol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; puerarin inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of IL1B protein]; pyrazolanthrone inhibits the reaction [[Lipopolysaccharides co-treated with Irinotecan] results in increased expression of and results in increased secretion of IL1B protein]; Quercetin inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Quercetin inhibits the reaction [NLRP3 protein promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]]; Quercetin promotes the reaction [Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]]; REG3A protein inhibits the reaction [daphnetin inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]]; RELB protein affects the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Resveratrol analog inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of and results in increased secretion of IL1B protein]; Resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of IL1B mRNA]; Resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with Nicotine] results in increased expression of IL1B mRNA]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Resveratrol promotes the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased secretion of IL1B protein]; Resveratrol promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Ribavirin inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Ribomunyl affects the reaction [Lipopolysaccharides affects the expression of IL1B protein]; Rotenone promotes the reaction [[Acrolein co-treated with Lipopolysaccharides] results in increased expression of IL1B protein]; RU24782 inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; RU24858 inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; SB 203580 inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; scalaradial inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; SIGIRR protein results in decreased susceptibility to [Lipopolysaccharides results in increased secretion of IL1B protein]; Simvastatin promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Sirolimus inhibits the reaction [[Acrolein co-treated with Lipopolysaccharides] results in increased expression of IL1B protein]; SIRT1 protein inhibits the reaction [[Lipopolysaccharides co-treated with Nicotine] results in increased expression of IL1B mRNA]; SIRT1 protein inhibits the reaction [[Lipopolysaccharides co-treated with Nicotine] results in increased secretion of IL1B protein]; SIRT1 protein promotes the reaction [puerarin inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]]; SNHG14 mRNA promotes the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Sodium Salicylate inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of IL1B protein]; Sodium Salicylate inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Soot inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Sulfasalazine inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; surfactin peptide results in decreased susceptibility to [Lipopolysaccharides results in increased secretion of IL1B protein]; Telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Tetrachlorodibenzodioxin promotes the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; TGFBR2 protein affects the reaction [Uric Acid promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]]; thymoquinone inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Tin Fluorides inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of IL1B protein]; tin protoporphyrin IX inhibits the reaction [Plant Extracts inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]]; Titanium promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; TLR4 protein inhibits the reaction [Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]]; TLR4 protein promotes the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased expression of IL1B mRNA]; Triamcinolone Acetonide inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Tropisetron inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; TRPM7 protein inhibits the reaction [MIR17 inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]]; tyrosyl-valyl-alanyl-aspartic acid fluoromethyl ketone analog inhibits the reaction [[Cadmium Chloride co-treated with Lipopolysaccharides] results in increased cleavage of IL1B protein]; tyrosyl-valyl-alanyl-aspartic acid fluoromethyl ketone analog inhibits the reaction [[Lipopolysaccharides co-treated with Silicon Dioxide] results in increased secretion of IL1B protein]; tyrosyl-valyl-alanyl-aspartic acid fluoromethyl ketone analog inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; tyrosyl-valyl-alanyl-aspartic acid fluoromethyl ketone inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; ubiquinone-O inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of IL1B mRNA]; Uric Acid promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; USP18 protein inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Vehicle Emissions promotes the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; VX-745 inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; withaferin A inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; zinc chloride inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Zinc inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of IL1B protein]; Zinc inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Zinc Oxide analog inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; zinc protoporphyrin inhibits the reaction [Cilostazol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]]; zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]]; Ziram inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]
